These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 1933287)

  • 41. Lateral diffusion of CD4 on the surface of a human neoplastic T-cell line probed with a fluorescent derivative of the envelope glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV-1).
    Pal R; Nair BC; Hoke GM; Sarngadharan MG; Edidin M
    J Cell Physiol; 1991 May; 147(2):326-32. PubMed ID: 2040664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of HIV-1 infection and preservation of CD4 function by the binding of CPFs to gp120.
    Finberg RW; Diamond DC; Mitchell DB; Rosenstein Y; Soman G; Norman TC; Schreiber SL; Burakoff SJ
    Science; 1990 Jul; 249(4966):287-91. PubMed ID: 2115689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure.
    Moebius U; Clayton LK; Abraham S; Harrison SC; Reinherz EL
    J Exp Med; 1992 Aug; 176(2):507-17. PubMed ID: 1500858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD4-binding regions of human immunodeficiency virus envelope glycoprotein gp120 defined by proteolytic digestion.
    Pollard SR; Meier W; Chow P; Rosa JJ; Wiley DC
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11320-4. PubMed ID: 1763044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis.
    Ashkenazi A; Presta LG; Marsters SA; Camerato TR; Rosenthal KA; Fendly BM; Capon DJ
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7150-4. PubMed ID: 2402498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate.
    Martín-García J; Cocklin S; Chaiken IM; González-Scarano F
    J Virol; 2005 Jun; 79(11):6703-13. PubMed ID: 15890908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4+ T cell-proliferative responses to glycoprotein 120.
    Hioe CE; Jones GJ; Rees AD; Ratto-Kim S; Birx D; Münz C; Gorny MK; Tuen M; Zolla-Pazner S
    AIDS Res Hum Retroviruses; 2000 Jun; 16(9):893-905. PubMed ID: 10875615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction of a binding site for human immunodeficiency virus type 1 gp120 in rat CD4.
    Schockmel GA; Somoza C; Davis SJ; Williams AF; Healey D
    J Exp Med; 1992 Jan; 175(1):301-4. PubMed ID: 1730924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.
    Berger EA; Lifson JD; Eiden LE
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8082-6. PubMed ID: 1896455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trypsin-resistant gp120 receptors are upregulated on short-term cultured human epidermal Langerhans cells.
    Dezutter-Dambuyant C; Schmitt DA; Dusserre N; Hanau D; Kolbe HV; Kieny MP; Gazzolo L; Macé K; Pasquali JL; Olivier R
    Res Virol; 1991; 142(2-3):129-38. PubMed ID: 1896637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding.
    Celada F; Cambiaggi C; Maccari J; Burastero S; Gregory T; Patzer E; Porter J; McDanal C; Matthews T
    J Exp Med; 1990 Oct; 172(4):1143-50. PubMed ID: 2212945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lineage-Specific Differences between the gp120 Inner Domain Layer 3 of Human Immunodeficiency Virus and That of Simian Immunodeficiency Virus.
    Ding S; Medjahed H; Prévost J; Coutu M; Xiang SH; Finzi A
    J Virol; 2016 Nov; 90(22):10065-10073. PubMed ID: 27535053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HIV binding to its receptor creates specific epitopes for the CD4/gp120 complex.
    Gershoni JM; Denisova G; Raviv D; Smorodinsky NI; Buyaner D
    FASEB J; 1993 Sep; 7(12):1185-7. PubMed ID: 7690724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.
    Ghanem MH; Bolivar-Wagers S; Dey B; Hajduczki A; Vargas-Inchaustegui DA; Danielson DT; Bundoc V; Liu L; Berger EA
    Cytotherapy; 2018 Mar; 20(3):407-419. PubMed ID: 29306566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.
    Lin G; Baribaud F; Romano J; Doms RW; Hoxie JA
    J Virol; 2003 Jan; 77(2):931-42. PubMed ID: 12502809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.
    Yang QE; Stephen AG; Adelsberger JW; Roberts PE; Zhu W; Currens MJ; Feng Y; Crise BJ; Gorelick RJ; Rein AR; Fisher RJ; Shoemaker RH; Sei S
    J Virol; 2005 May; 79(10):6122-33. PubMed ID: 15857997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanisms.
    Yahi N; Fantini J; Baghdiguian S; Mabrouk K; Tamalet C; Rochat H; Van Rietschoten J; Sabatier JM
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4867-71. PubMed ID: 7761414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.
    Rieber EP; Federle C; Reiter C; Krauss S; Gürtler L; Eberle J; Deinhardt F; Riethmüller G
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10792-6. PubMed ID: 1438278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.